Abstract:Background: Osteoporosis (OP) is a metabolic bone disease syndrome for which there is no good treatment. In this study, we investigated the expression changes of miR-181c-5p in osteoporosis-derived BMMSCs, and the role and molecular mechanism in the osteogenic-lipogenic differentiation of BMMSCs. Methods: In this study, an OP mouse model was successfully established using the ovariectomy method, and osteoporotic-derived BMMSCs (O-BMMSCs) and sham-operated-derived BMMSCs (S-BMMSCs) were isolated and cultured using the whole bone marrow method. A genetic screen revealed that miR-181c-5p was differentially expressed in O-BMMSCs and S-BMMSCs. The expression levels of miR-181c-5p in BMMSCs were overexpressed or inhibited by cell transfection, and the regulatory effects of miR-181c-5p on the proliferation and osteogenic-adipogenic differentiation of BMMSCs were examined using MTT, multi-directional differentiation induction, alizarin red staining, oil red O staining, qRT-PCR and Western blot. Candidate target genes for miR181c-5p were screened by target gene prediction software and bioinformatics websites, and target gene validation was performed. Results: The study found that overexpression of miR-181c-5p or inhibition of miR-181c-5p had no significant effect on the proliferation ability of BMMSCs. Upregulation of miR-181c-5p could reduce the osteogenic ability and enhance the adipogenic ability of BMMSCs, while downregulation of miR-181c-5p could increase the osteogenic ability and inhibit the adipogenic ability of BMMSCs. Besides, Foxo1 was confirmed as a direct target gene of miR-181c-5p, and miR-181c-5p negatively regulated Foxo1 expression. Downregulation of miR-181c-5p in O-BMMSCs promoted Foxo1 expression, improved the osteogenic differentiation of O-BMMSCs, and reduced abnormal lipogenic differentiation of O-BMMSCs and eventually partially restored the normal differentiation ability of O-BMMSCs. Conclusion: miR-181c-5p regulated the osteogenic and adipogenic differentiation of BMMSCs by negatively regulating the expression of target gene Foxo1. The overexpression of miR-181c-5p in the process of osteoporosis leads to the disruption of the balance of osteogenic and adipogenic differentiation of BMMSCs, and reduces the bone formation ability of stem cells.

Impact of estrogen on the Notch signaling pathway in human bone mesenchymal stem cells derived from patients with postmenopausal osteoporosis

Estrogen improves the proliferation and differentiation of hBMSCs derived from postmenopausal osteoporosis through notch signaling pathway

Inhibition of osteogenic and adipogenic potential in bone marrow-derived mesenchymal stem cells under osteoporosis

The Regulatory Effect of Mir-181c-5p On the Differentiation Function of Bone Marrow Mesenchymal Stem Cells in Postmenopausal Osteoporotic Mice

Could the Effect of Modeled Microgravity on Osteogenic Differentiation of Human Mesenchymal Stem Cells Be Reversed by Regulation of Signaling Pathways?

Exosomal miR-186 derived from BMSCs promote osteogenesis through hippo signaling pathway in postmenopausal osteoporosis

In vitro cell behaviors of bone mesenchymal stem cells derived from normal and postmenopausal osteoporotic rats

miR-18a-5p promotes osteogenic differentiation of BMSC by inhibiting Notch2

[Effect of Estrogen on Osteoprotegerin, Osteoclast Differentiation Factor and Macrophage Colony Stimulating Factor Mrna Expressions in Ovariectomized Rat Bone Tissue].

Differential responsiveness to 17β-estradiol of mesenchymal stem cells from postmenopausal women between osteoporosis and osteoarthritis

Estrogen promotes lncRNA H19 expression to regulate osteogenic differentiation of BMSCs and reduce osteoporosis via miR-532-3p/SIRT1 axis

Identification of potential specific biomarkers and key signaling pathways between osteogenic and adipogenic differentiation of hBMSCs for osteoporosis therapy

Notch signaling and fluid shear stress in regulating osteogenic differentiation

Possible mechanisms underlying the regulation of postmenopausal osteoporosis by follicle-stimulating hormone

Effects of 17 beta-estradiol on osteogenic differentiation of rat primary cultured bone marrow mesenchymal stem cells

[The Effect of Estrogen on Proliferation and Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells].

Estrogen deficiency leads to impaired osteogenic differentiation of periodontal ligament stem cells in rats.

Osteogenic Potential and Responsiveness to Leptin of Mesenchymal Stem Cells Between Postmenopausal Women with Osteoarthritis and Osteoporosis.

Exosomal hsa_circ_0006859 is a potential biomarker for postmenopausal osteoporosis and enhances adipogenic versus osteogenic differentiation in human bone marrow mesenchymal stem cells by sponging miR-431-5p

Effects of 17Β-Estradiol on Osteogenic and Adipogenic Differentiation of Bone Marrow Stromal Cells and Adipocytic Trans-Differentiation of Osteoblasts

In vivo genome-wide expression study on human circulating B cells suggests a novel ESR1 and MAPK3 network for postmenopausal osteoporosis.